Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01616797
Recruitment Status : Completed
First Posted : June 12, 2012
Last Update Posted : September 7, 2018
Sponsor:
Information provided by (Responsible Party):
Amit Etkin, Stanford University

Brief Summary:
The research proposes to use an innovative solution to shape brain circuits that support executive function and emotion reactivity -using targeted neurobehavioral intervention.

Condition or disease Intervention/treatment Phase
Depression, Anxiety Cognitive Training Emotion Training Emotion Regulation Behavioral: Computerized neurobehavioral intervention Not Applicable

Detailed Description:
Participants will be recruited locally in the San Francisco Bay area with certain symptoms of anxiety and depression. They will complete a clinical assessment and then take part in a cognitive-emotion training delivered online.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 68 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression
Study Start Date : February 2014
Actual Primary Completion Date : August 2018
Actual Study Completion Date : August 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arm Intervention/treatment
Experimental: Computerized intervention
Participants will be asked to visit a customized website and engage in computerized exercises. Cognitive and emotion training games.
Behavioral: Computerized neurobehavioral intervention
Participants will complete the intervention by logging into a secure online website and complete computerized neurobehavioral tasks. Tasks will train the following - cognitive control, working memory and task shifting with two different tasks that engage these skills and positivity biases.

Sham Comparator: Control
Participants will be asked to visit a customized website and engage in computerized games.
Behavioral: Computerized neurobehavioral intervention
Participants will complete the intervention by logging into a secure online website and complete computerized neurobehavioral tasks. Tasks will train the following - cognitive control, working memory and task shifting with two different tasks that engage these skills and positivity biases.




Primary Outcome Measures :
  1. Completion [ Time Frame: 60 days ]
    We anticipate that participants will complete at least 30-days of the intervention.

  2. Proximal outcomes [ Time Frame: 60 days ]
    We anticipate that proximal measures of symptoms will show improvement following the training in terms of emotional reactivity, implicit emotion regulation, negative emotional memory bias, attentional bias for threat, executive functions behaviorally and N-back during fMRI as well as resting-state fMRI connectivity.

  3. Distal outcomes [ Time Frame: 5 months ]
    We anticipate that anxiety and depression symptoms, explicit emotion regulation capacities and quality of life reported on self-report measures will show improvement.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of depression on the SCID, a total Ham-D≥16 and Ham-D anxiety/somatization subscale ≥ 7.

Exclusion Criteria:

  • Current medication for psychiatric disorders
  • Pregnant females
  • Head trauma or injury that resulted in loss of consciousness
  • MRI contraindication

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01616797


Locations
Layout table for location information
United States, California
VA Palo Alto Health Care System (VAPAHCS)
Palo Alto, California, United States, 94304
Stanford University Department of Pscyhiatry and Behavioral Sciences
Stanford, California, United States, 94304
Sponsors and Collaborators
Stanford University

Additional Information:
Layout table for additonal information
Responsible Party: Amit Etkin, Principle Investigator, Stanford University
ClinicalTrials.gov Identifier: NCT01616797     History of Changes
Other Study ID Numbers: IRB-24813
First Posted: June 12, 2012    Key Record Dates
Last Update Posted: September 7, 2018
Last Verified: September 2018

Additional relevant MeSH terms:
Layout table for MeSH terms
Depression
Depressive Disorder
Anxiety Disorders
Behavioral Symptoms
Mood Disorders
Mental Disorders